Is the removal of a central venous catheter always necessary in the context of catheter-related right atrial thrombosis?


Journal

The journal of vascular access
ISSN: 1724-6032
Titre abrégé: J Vasc Access
Pays: United States
ID NLM: 100940729

Informations de publication

Date de publication:
Jan 2019
Historique:
pubmed: 12 5 2018
medline: 10 4 2019
entrez: 12 5 2018
Statut: ppublish

Résumé

Catheter-related right atrial thrombosis is a severe and life-threatening complication of central venous catheters in both adult and young patients. Catheter-related right atrial thrombosis can occur with any type of central venous catheters, utilized either for hemodialysis or infusion. Up to 30% of patients with central venous catheter are estimated to be affected by catheter-related right atrial thrombosis; however, neither precise epidemiological data nor guidelines regarding medical or surgical treatment are available. This complication seems to be closely associated with positioning of the catheter tip in the atrium, whereas it is unlikely with a tip located within superior vena cava. Herein, we report the case of a patient affected by catheter-related right atrial thrombosis, who showed a quick resolution of thrombosis with a new therapeutic scheme combining loco-regional thrombolytic therapy (urokinase as a locking solution) and systemic anticoagulation therapy (vitamin K antagonists), thus avoiding catheter removal. Neither complications of the combination therapy were reported, nor recurrence of catheter-related right atrial thrombosis occurred. In conclusion, the combination therapy here described was safe, quick and effective, achieving the goal of not removing the catheter.

Identifiants

pubmed: 29749281
doi: 10.1177/1129729818774438
doi:

Substances chimiques

Anticoagulants 0
Fibrinolytic Agents 0
Urokinase-Type Plasminogen Activator EC 3.4.21.73

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

98-101

Auteurs

Luigi Rossi (L)

1 Division of Nephrology, Miulli General Hospital, Acquaviva delle Fonti, Italy.

Pasquale Libutti (P)

1 Division of Nephrology, Miulli General Hospital, Acquaviva delle Fonti, Italy.

Francesco Casucci (F)

1 Division of Nephrology, Miulli General Hospital, Acquaviva delle Fonti, Italy.

Piero Lisi (P)

1 Division of Nephrology, Miulli General Hospital, Acquaviva delle Fonti, Italy.

Annalisa Teutonico (A)

1 Division of Nephrology, Miulli General Hospital, Acquaviva delle Fonti, Italy.

Carlo Basile (C)

2 Clinical Research Branch, Division of Nephrology, Miulli General Hospital, Acquaviva delle Fonti, Italy.

Carlo Lomonte (C)

1 Division of Nephrology, Miulli General Hospital, Acquaviva delle Fonti, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH